PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Journal of Korean Diabetes10.4093/jkd.2021.22.3.2072021223207-219Combined Effects of Insulin Resistance and Inflammation on Comorbidities of Type 2 DiabetesEun Jung Kim, Eun Young Lee, Yong-Ho Lee, Young Ju Choi, Seok Won Park, Eun Jig Lee, Hyun Chul Lee, Kap Bum Huhhttp://e-jkd.org/upload/pdf/jkd-2021-22-3-207.pdf, http://e-jkd.org/journal/view.php?doi=10.4093/jkd.2021.22.3.207, http://e-jkd.org/upload/pdf/jkd-2021-22-3-207.pdf
International Journal of Clinical Practice10.1111/j.1742-1241.2004.00318.x2004589867-876Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetesC.J. Bailey, C. Dayhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-1241.2004.00318.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2004.00318.x/fullpdf
Neuromodulation10.1016/b978-0-12-805353-9.00133-920181565-1573Insulin Resistance, Glucose Metabolism, Inflammation, and the Role of Neuromodulation as a Therapy for Type-2 DiabetesJ.P. Erricohttps://api.elsevier.com/content/article/PII:B9780128053539001339?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128053539001339?httpAccept=text/plain
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging10.1016/b978-0-12-801033-4.00014-x2015213-235Regulation of Autophagy in Insulin Resistance and Type 2 DiabetesMonika Cahovahttps://api.elsevier.com/content/article/PII:B978012801033400014X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B978012801033400014X?httpAccept=text/plain
Pediatric Diabetes10.1111/pedi.123372015178545-558Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetesFida Bacha, Sara Klinepeter Bartzhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fpedi.12337, http://onlinelibrary.wiley.com/wol1/doi/10.1111/pedi.12337/fullpdf
Practical Diabetes International10.1002/pdi.15322010279388-390Insulin resistance in type 1 diabetes: a recipe for double diabetes?S Clelandhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpdi.1532, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpdi.1532, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pdi.1532/fullpdf
Pediatric Type II Diabetes10.1016/b978-0-323-55138-0.00001-220191-8Pathophysiology of Insulin Resistance and Type 2 DiabetesRam Weisshttps://api.elsevier.com/content/article/PII:B9780323551380000012?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323551380000012?httpAccept=text/plain
Glucose Intake and Utilization in Pre-Diabetes and Diabetes10.1016/b978-0-12-800093-9.00008-9201595-101Insulin Resistance and InflammationGuenther Bodenhttps://api.elsevier.com/content/article/PII:B9780128000939000089?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128000939000089?httpAccept=text/plain
Diabetes Research and Clinical Practice10.1016/s0168-8227(08)70647-8200879S2Plenary 3 Role of inflammation in the etiology of obesity induced insulin resistance and Type 2 diabetesMark A. Febbraiohttps://api.elsevier.com/content/article/PII:S0168822708706478?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168822708706478?httpAccept=text/plain
Atherosclerosis Supplements10.1016/s1567-5688(08)70152-120089139INSULIN RESISTANCE AND TYPE 2 DIABETES: IMPROVING INSULIN RESISTANCE IN TYPE 2 DIABETES NORMALIZES LDL PARTICLE DISTRIBUTIONA.F. Ayyobi, J.D. Brunzellhttps://api.elsevier.com/content/article/PII:S1567568808701521?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1567568808701521?httpAccept=text/plain